Kaplan Fox investigates securities violations at multiple healthcare firms

Law firm Kaplan Fox & Kilsheimer LLP is conducting multiple investigations into potential securities law violations involving several healthcare-related companies.

Alignment Healthcare, Inc. is under investigation following a whistleblower complaint alleging accounting irregularities. The complaint claims the company artificially inflated financial results, including Adjusted EBITDA, by misclassifying millions of dollars in operating expenses as capital expenditures. This news led to a 16.7% drop in the company's stock price in July 2026.

Medline Inc. is also being investigated after the FDA issued a warning letter regarding significant violations of Current Good Manufacturing Practice regulations. The FDA cited failures to investigate microbial contamination and inadequate cleaning practices, which resulted in a 7.16% decline in Medline's stock.

Hims & Hers Health, Inc. is facing investigation following legal action from the FTC and various state entities. The allegations include failing to disclose immediate prescription charges, making subscription cancellations difficult, and sharing consumer health information with third parties such as Meta and Snap.